Characterization of minor site probes for human serum albumin by high- performance affinity chromatography

Arundhati Sengupta, David S Hage

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

This study used high-performance affinity chromatography (HPAC) and immobilized human serum albumin (HSA) columns to examine the specificity and cross-reactivity of various compounds that have been proposed as markers for the minor binding sites of HSA. These agents included acetyldigitoxin and digitoxin as probes for the digitoxin site, phenol red as a probe for the bilirubin site, and cis- or trans-clomiphene as markers for the tamoxifen site. None of these probes showed any significant binding at HSA's indole- benzodiazepine site. However, phenol red did bind at the warfarin- azapropazone site of HSA, and cis/trans-clomiphene gave positive allosteric effects caused by the binding of warfarin to HSA. Digitoxin and acetyldigitoxin were found to bind to a common, unique region on HSA; cis- and trans-clomiphene also appeared to interact at a unique site, although trans-clomiphene displayed additional direct competition with phenol red. From these results it was possible to develop a model that described the general relationship between these binding regions on HSA. This information should be useful in future studies that employ HPAC for characterizing the binding of HSA to other drugs or clinical agents.

Original languageEnglish (US)
Pages (from-to)3821-3827
Number of pages7
JournalAnalytical Chemistry
Volume71
Issue number17
DOIs
StatePublished - Sep 1 1999

Fingerprint

Affinity chromatography
Enclomiphene
Serum Albumin
Digitoxin
Phenolsulfonphthalein
Acetyldigitoxins
Warfarin
Apazone
Tamoxifen
Benzodiazepines
Bilirubin
Binding Sites
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Characterization of minor site probes for human serum albumin by high- performance affinity chromatography. / Sengupta, Arundhati; Hage, David S.

In: Analytical Chemistry, Vol. 71, No. 17, 01.09.1999, p. 3821-3827.

Research output: Contribution to journalArticle

@article{f9d55217c0c347b184f86066fc9a468f,
title = "Characterization of minor site probes for human serum albumin by high- performance affinity chromatography",
abstract = "This study used high-performance affinity chromatography (HPAC) and immobilized human serum albumin (HSA) columns to examine the specificity and cross-reactivity of various compounds that have been proposed as markers for the minor binding sites of HSA. These agents included acetyldigitoxin and digitoxin as probes for the digitoxin site, phenol red as a probe for the bilirubin site, and cis- or trans-clomiphene as markers for the tamoxifen site. None of these probes showed any significant binding at HSA's indole- benzodiazepine site. However, phenol red did bind at the warfarin- azapropazone site of HSA, and cis/trans-clomiphene gave positive allosteric effects caused by the binding of warfarin to HSA. Digitoxin and acetyldigitoxin were found to bind to a common, unique region on HSA; cis- and trans-clomiphene also appeared to interact at a unique site, although trans-clomiphene displayed additional direct competition with phenol red. From these results it was possible to develop a model that described the general relationship between these binding regions on HSA. This information should be useful in future studies that employ HPAC for characterizing the binding of HSA to other drugs or clinical agents.",
author = "Arundhati Sengupta and Hage, {David S}",
year = "1999",
month = "9",
day = "1",
doi = "10.1021/ac9903499",
language = "English (US)",
volume = "71",
pages = "3821--3827",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "17",

}

TY - JOUR

T1 - Characterization of minor site probes for human serum albumin by high- performance affinity chromatography

AU - Sengupta, Arundhati

AU - Hage, David S

PY - 1999/9/1

Y1 - 1999/9/1

N2 - This study used high-performance affinity chromatography (HPAC) and immobilized human serum albumin (HSA) columns to examine the specificity and cross-reactivity of various compounds that have been proposed as markers for the minor binding sites of HSA. These agents included acetyldigitoxin and digitoxin as probes for the digitoxin site, phenol red as a probe for the bilirubin site, and cis- or trans-clomiphene as markers for the tamoxifen site. None of these probes showed any significant binding at HSA's indole- benzodiazepine site. However, phenol red did bind at the warfarin- azapropazone site of HSA, and cis/trans-clomiphene gave positive allosteric effects caused by the binding of warfarin to HSA. Digitoxin and acetyldigitoxin were found to bind to a common, unique region on HSA; cis- and trans-clomiphene also appeared to interact at a unique site, although trans-clomiphene displayed additional direct competition with phenol red. From these results it was possible to develop a model that described the general relationship between these binding regions on HSA. This information should be useful in future studies that employ HPAC for characterizing the binding of HSA to other drugs or clinical agents.

AB - This study used high-performance affinity chromatography (HPAC) and immobilized human serum albumin (HSA) columns to examine the specificity and cross-reactivity of various compounds that have been proposed as markers for the minor binding sites of HSA. These agents included acetyldigitoxin and digitoxin as probes for the digitoxin site, phenol red as a probe for the bilirubin site, and cis- or trans-clomiphene as markers for the tamoxifen site. None of these probes showed any significant binding at HSA's indole- benzodiazepine site. However, phenol red did bind at the warfarin- azapropazone site of HSA, and cis/trans-clomiphene gave positive allosteric effects caused by the binding of warfarin to HSA. Digitoxin and acetyldigitoxin were found to bind to a common, unique region on HSA; cis- and trans-clomiphene also appeared to interact at a unique site, although trans-clomiphene displayed additional direct competition with phenol red. From these results it was possible to develop a model that described the general relationship between these binding regions on HSA. This information should be useful in future studies that employ HPAC for characterizing the binding of HSA to other drugs or clinical agents.

UR - http://www.scopus.com/inward/record.url?scp=0033199140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033199140&partnerID=8YFLogxK

U2 - 10.1021/ac9903499

DO - 10.1021/ac9903499

M3 - Article

VL - 71

SP - 3821

EP - 3827

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 17

ER -